Introduction
The intake of dietary saturated fat and cholesterol in various populations correlates directly with the incidence of coronary heart disease in those populations (1) . It has also been shown that experimental animals develop atherosclerosis resulting from hyperlipidemia induced by diets high in fat and cholesterol (2, 3) . One mechanism thought to be important in diet-induced atherogenesis is the receptor-mediated uptake oflipoproteins by macrophages in the arterial wall, a process that ultimately leads to lipid accumulation and foam cell formation (for review, see References 3 and 4).
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The lipoproteins postulated to participate in foam cell formation are referred to as beta-very low density lipoproteins (,B-VLDL) (4) (5) (6) (7) (8) . The #l-VLDL accumulate in the plasma ofanimals fed fat and cholesterol and in the plasma of patients with type III hyperlipoproteinemia. The f3-VLDL induced by diet and present in type III patients are oftwo types: fraction I, ofintestinal origin, representing chylomicron remnants, and fraction II, of hepatic origin, representing VLDL remnants (8) . When incubated with mouse peritoneal macrophages, both f3-VLDL fractions are capable of causing massive cholesteryl ester accumulation in these cells, giving them the appearance of foam cells (8) (9) (10) (11) (12) . Other naturally occurring lipoproteins, including low density lipoproteins (LDL), do not induce the same massive cholesteryl ester accumulation in these cells. The uptake of the f3-VLDL is receptor-mediated (5, 6, 10, 11) . Van Lenten et al. (13) have shown that postprandial plasma from one human subject contained lipoproteins of d < 1.006 g/ml that bound to the ,B-VLDL receptor on macrophages. Furthermore, it has been postulated that transiently present postprandial lipoproteins resembling f3-VLDL may occur in humans and may be responsible for the accelerated coronary artery disease associated with dietary fat and cholesterol consumption (4, 7, 8, 14) .
Another lipoprotein thought to be atherogenic is lipoprotein (a) [Lp(a)]' (15) , which has been shown to occur in the plasma of fasting subjects, primarily in the density range of 1.05-1.125 g/ml (16, 17) . The Lp(a) isolated by ultracentrifugation and purified by column chromatography contains a specific apolipoprotein, apolipoprotein [a] (apo [a] ), which has not been detected in any other lipoprotein obtained from the plasma of fasting individuals (18, 19) . Apo B100 is also a major apolipoprotein constituent of Lp(a) and probably accounts for the binding of Lp(a) to the apo B,E(LDL) receptor (20, 21) . Levels of Lp(a) in plasma vary, ranging from barely detectable to nearly 100 mg/dl (22) (23) (24) . A distinguishing characteristic ofLp(a) is its high sialic acid content, which is four-to sixfold greater than that of LDL (16) . Dietary manipulation, including prolonged fasting, has not been shown to cause changes in the plasma levels of Lp(a) or changes in the distribution of Lp(a) among the lipoprotein classes (18, 23) . However, there have been no detailed studies of apo [a] in lipoproteins during the acute postprandial state.
The assumed association of Lp(a) with atherogenesis is based on a direct correlation between plasma Lp(a) concentrations and the incidence of clinically evident coronary atherosclerosis (15, 23 The pathophysiology underlying these associations, however, is not understood.
The purpose of the present study was to determine if chylomicrons or chylomicron remnants capable of binding to macrophage receptors in vitro are produced in humans after the ingestion of a single, high-saturated-fat, or high-saturated-fat and high-cholesterol meal, and if lipid accumulation occurs in the macrophages as a consequence of this binding. In these studies, when plasma was procured during the postprandial state, a fraction of the d < 1.006 lipoproteins similar to chylomicron remnants was isolated and shown to bind avidly to receptors on macrophages, causing triglycerides to accumulate in these cells.
The fraction that bound most avidly was enriched in apo [a] . 
Methods
Volunteers. Subjects had appropriate medical histories taken and physical examinations and a laboratory screening were performed to ascertain that they were in good health. Informed consent was obtained.
Dietary studies. The studies were conducted in the metabolic ward of the General Clinical Research Center, San Francisco General Hospital, where the formula diets were prepared. All subjects ate their usual diets prior to the study and abstained from alcohol 3 d prior to and during the study. Subjects fasted 12 h before consuming each ofthe two separate formula meals on consecutive days, day I and day 2, of the study. The subjects ate as they wished after the formula meal on day I and prior to beginning the 12-h fast required for the next day's study. The formula meal on day I consisted oflard, 64 g; dextrose, 32 g; and powdered skim milk, which provided 40 g of carbohydrate and 27 g of protein.
There were 972 total calories in the formula meal. 12 egg yolks were added to the above formula in preparing the formula meal for day 2. The egg yolks provided an additional 67 g of fat, 34 g of protein, and -3.0 g of cholesterol. There were 1,71 1 calories in the high-fat and high-cholesterol meal.
To obtain sufficient amounts of plasma, 3 U of blood (-250-300 ml/U) were taken from each subject using the manual method of plasmapheresis. Each unit of blood required 5-10 min to procure, and the 3 U were collected -2.5, 3.25, and 4.0 h after ingestion of the formula meals. The packed cells were reinfused after each unit was drawn, along with a volume of saline equal to that of the plasma that was removed.
Lipoprotein isolation and subfractionation. Aliquots were removed from each unit of plasma to determine plasma lipid and lipoprotein cholesterol concentrations (26 (27) .
The Lp(a) used in these studies was isolated from the plasma of two subjects. One was a normolipidemic individual whose (29) . Plasma apo E concentrations were determined by radioimmunoassay (30) .
Cultured mouse macrophages. Unstimulated peritoneal macrophages were harvested in sterile saline from Swiss-Webster mice as described (9) . The macrophages in the peritoneal lavage were identified by size distribution analysis employing a Channelyzer (Coulter Electronics, Inc., Hialeah, FL), and the cells suspended in Dulbecco's modified Eagle's medium (DME) were plated at 5 X 101 macrophages per 16-mm petri dish. After 2 h, the cells were washed three times with DME and then incubated in a humidified CO2 (7.5%) incubator overnight in DME containing 20% fetal calf serum before they were used in an experiment.
Lipoprotein binding and degradation. Radioiodinated fl-VLDL from patients with type III hyperlipoproteinemia (8, 31) or from cholesterolfed dogs (32) were prepared with iodine-125 (1251) (33) . Binding and cellular proteolytic degradation were determined by previously published procedures (34, 35). The details of each experiment are given in the respective figure caption or table legend.
Polyacrylamide gel electrophoresis. Tube gel electrophoresis employing 4% and 11% polyacrylamide containing 0.1% sodium dodecyl sulfate (SDS) and slab gel electrophoresis were performed as previously described (36, 37) . Electroelution was employed to free apolipoproteins from polyacrylamide gels after preparative slab gel electrophoresis (38).
Immunoblotting. Immunoblotting was performed as described by Daniel et al. (39) . After electrophoretic transfer of apolipoproteins from slab gels, the nitrocellulose paper was incubated with monoclonal antibodies specific for apo B100 (18C4) or apo B100 and apo B48 (81A1). The antibody 18C4, exhibiting apo B100 specificity, has been previously described (40) . The antibody 81A1 was prepared as described for antibody 18C4, except apo B48 isolated from human lymph was used as the immunogen instead of human LDL (40) . The positive clones were identified by screening against isolated apo B48. All the positive clones produced antibody that cross-reacted against apo B100, including 81A1. A polyclonal antibody specific for apo[a] was also used. This antibody was prepared by immunizing a rabbit with Lp(a), harvesting the serum, and then passing this antiserum through an agarose-apo B100 affinity column to remove antibodies to apo B100 (41) . After this affinity chromatography was performed, the antiserum failed to react with LDL, apo B100, or VLDL isolated from fasting subjects as determined by Ouchterlony double diffusion and by Western blot analysis.
Cellular accumulation oftriglyceride and cholesterol. After the mouse peritoneal macrophages were incubated with various lipoproteins, the cells were harvested, and the amounts of cellular triglyceride, cholesterol, cholesteryl ester, and protein were measured (42). Precise details of the experiment are given in the legend to Table III . Protein was measured according to Lowry et al. (43) .
Amino acid composition. Samples to be analyzed were hydrolyzed in 6 N HCO for 20 h at 1 10°C in sealed, evacuated tubes. Amino acid analyses were performed as previously described (28, 44) .
Sialic acid measurement. The sialic acid content of lipoproteins or apolipoproteins was determined by the thiobarbituric acid assay method (45) .
Results
Description of volunteers. All subjects were normolipidemic ( Binding and degradation offasting VLDL and postprandial d < 1.006fractions by mouse peritoneal macrophages. The postprandial d < 1.006 lipoproteins were much more effective than fasting VLDL in inhibiting both '25I-f3-VLDL binding and uptake ( Fig. 1) and degradation ( Fig. 1) (a representative experiment) . (Fig. 3) . Based on logit-log analysis of the data in Fig. 3 , the fraction I lipoproteins were approximately threefold more active than the fraction II lipoproteins in competing with '25I-f3-VLDL for binding. There were no apparent differences between d < 1.006 lipoproteins (fractions I and II) isolated after lard ingestion and the same fractions obtained after the lard and eggs meal.
Lipid accumulation by macrophages. To determine whether the mass of the cellular lipids increased, the triglyceride, cholesterol, and cholesteryl ester contents of the macrophages were determined after incubation with fasting VLDL or postprandial d < 1.006 lipoproteins. No measurable triglyceride was detected in cells that had been incubated with culture medium alone, amide slab gel electrophoresis (Fig. 5) . The gels were then blotted to nitrocellulose paper, which was subsequently incubated with antibodies to either apo B 100 (18C4), apo B100 and apo B48 (81A1), or apo[a] of Lp(a) ( plied to the 4% slab gel. After the gels were electrophoresed, they were blotted with nitrocellulose paper, and the blots were then incubated with the indicated antibodies. A second incubation with '25I-antimouse immunoglobulin G, or '25I-Protein A in the case of the antiLp(a), was then followed by exposure of the blots to x-ray film. 626 and fraction I lipoproteins. Antibodies to apo B100 and apo B48 failed to react with the Lp(a)-specific apolipoprotein (Fig. 5) .
The amount of apo[a] present in the postprandial d < 1.006 lipoproteins varied from one individual to another. However, in all six subjects a readily detectable band corresponding to apo[a] was observed on SDS-polyacrylamide gels of fraction I postprandial d < 1.006 lipoproteins. Fraction I lipoproteins were also enriched in apo B48 and apo E as compared to fraction II lipoproteins (Fig. 4) . There was no apparent difference between the lard or the lard plus eggs meal with regard to the content of apo B48, apo E, or the Lp(a)-specific apolipoproteins in the postprandial d < 1.006 lipoproteins from the six subjects.
The apo[a] of both postprandial d < 1.006 lipoproteins and Lp(a) was compared by gradient gel electrophoresis (2-6% acrylamide). The Lp(a) used in these studies was from a patient (D.R.) with type III hyperlipoproteinemia. The delipidated apolipoproteins were solubilized in 5% SDS, and the electrophoresis was carried out with unreduced samples and samples reduced by the addition of 1% 2-mercaptoethanol (Fig. 6) . (Fig. 6) poproteins ofboth Lp(a) and postprandial d < 1.006 lipoproteins. The delipidated apolipoproteins were solubilized in 5% SDS and 1% 2-mercaptoethanol to reduce the apo[a] * apo B100 disulfide bonds, and the various forms ofapo[a] could be clearly separated from the apo B 100 on the preparative gels. The three subspecies of apo [a] were electroeluted from the preparative gels, and the amino acid composition and sialic acid content of each subspecies was determined.
The amino acid compositions of the three apo[a] subspecies were nearly identical but differed distinctly from those of apo B 100 and apo B48 (Table IV) . The apo[a] subspecies were enriched in proline and contained relatively little lysine, as well as small amounts of the hydrophobic residues, isoleucine, leucine, and phenylalanine. The sialic acid content of the three apo [a] subspecies was also determined (Table V) in the postprandial d < 1.006 lipoproteins within 2 or 3 h of the consumption of a high-fat meal. Second, despite the fact that apo B48 is the principal form of apo B synthesized by the intestine, the intestine may synthesize apo B100 that can be complexed with apo[a] in the chylomicrons. A small amount of apo B100 has been detected in human thoracic duct lymph chylomicrons and has been shown to occur in mesenteric lymph chylomicrons synthesized by isolated, perfused segments of rat jejunum (49, 50) . In addition, it has been shown recently that apo B100 mRNA could be detected in human and rhesus monkey small intestine at significant levels (5 1 
